Sees FY24 adjusted EBITDA of $395M-$405M. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analysts >> Read More on COLL: Is COLL a Buy, Before Earnings? Collegium Pharmaceutical management to meet with Piper Sandler